WISDOMTREE DREYFUS (AMEX:EU)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $20.95 |
| Daily Range | $20.79 - $21.00 |
| 52-Week Range | $19.05 - $24.45 |
| Market Cap | $4.71M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | 0.74 (4.90%) |
| Volume | 0 |
| Average Daily Volume | 0 |
How do you think EU will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
EU Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
EU News and Commentary
- India Caught Between Western Sanctions and Iran – NASDAQ
- Futures Flat on Greek Debt Uncertainty; CSCO, PEP in Focus – NASDAQ
- How Does Another Greek Rescue Deal Impact the euro? – NASDAQ
- Stocks Set to Slide Ahead of Bernanke Testimony – NASDAQ
- Novo Nordisk Posts Solid 4Q - Analyst Blog – NASDAQ
- Stocks Set to Pull Back as Greek Debt Drama Rages On – NASDAQ
- Gilead Misses EPS Ests, Sales Up - Analyst Blog – NASDAQ
- Opening View: Futures Point Higher on Promising Euro-Zone Progress; PFE in Focus – NASDAQ
- UCB's Keppra Gets FDA Nod - Analyst Blog – NASDAQ
- NVS Beats by a Penny, View Guarded - Analyst Blog – NASDAQ
- Stock Market News for January 27, 2012 - Market News – NASDAQ
- Novartis Drugs Backed by CHMP - Analyst Blog – NASDAQ
- Stock Market News for January 25, 2012 - Market News – NASDAQ
- Metals and Energy Trading Outlook – NASDAQ
- Chemical Industry Stock Outlook - Jan. 2012 - Industry Outlook – NASDAQ
- Stock Market News for January 24, 2012 - Market News – NASDAQ
- How Europe Should Tackle Its Three Main Problems – Minyanville
- Opening View: Futures Mixed as Wall Street Weighs Big-Cap Earnings – NASDAQ
- Vivus' ED Drug Continues to Hold Up - Analyst Blog – NASDAQ
- Europe's Road to Nowhere, Part 2 – Minyanville

RSS Headlines
Fool UK